Additive Effects of Streptozotocin and Aluminum Chloride on Cognitive Decline and Brain Damage in Rats: A Behavioral and Histopathological
DOI:
https://doi.org/10.54361/LJMR.20.1.15Keywords:
Steptozotocin, Aluminum chloride, cognitive impairmentAbstract
Background: Streptozotocin (STZ) and Aluminum Chloride (AlCl₃) are recognized neurotoxins implicated in models of cognitive decline and neurodegeneration. This study investigated the comparative effects of STZ, AlCl₃, and their combination on cognitive performance and brain structural integrity. Methods: Cognitive function was assessed using the T-maze test, and structural damage was evaluated through histopathological examination of brain tissue across four groups: Control, STZ-treated, AlCl₃-treated, and Combination-treated. Results: All three treatment groups showed significant cognitive impairment and histopathological changes compared to the Control group. In the T-maze test, the Combination group exhibited the maximum degree of cognitive impairment, showing a significantly greater deficit than either the STZ or AlCl₃ groups alone. In contrast, histopathological assessment revealed that the magnitude of cellular and structural impairment was comparable across the STZ, AlCl₃, and Combination groups, though all were significantly different from the Control. Conclusion: Co-exposure to STZ and AlCl₃ leads to a marked synergistic or additive effect on behavioral neurotoxicity, resulting in maximal cognitive deficits. However, the histopathological evidence suggests that the individual agents (STZ or AlCl₃) may already induce a comparable level of maximal structural damage, indicating a dissociation between the severity of morphological and functional impairment under these experimental conditions.
Downloads
References
1. Hamed S. Brain Injury with Diabetes Mellitus: Evidence, Mechanisms and Treatment Implications.Expert Rev. Clin Pharmacol 2017;10:409–28.
2. IDF IDF. Facts & figures 2025 [Available from: https://idf.org/about-diabetes/diabetes-facts-figures/.
3. D Baglietto-Vargas, Shi J, Yaeger D, Ager R, LaFerla F. Diabetes and Alzheimer’s Disease Crosstalk. Neurosci Biobehav Rev 2016;64:272–87.
4. Clinic M. Alzheimer’s disease - Symptoms and causes 2024 [Available from: Retrieved from https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447.
5. DeTure M, Dickson D. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019;14(1).
6. Weaver D. Thirty Risk Factors for Alzheimer’s Disease Unified by a Common Neuroimmune–Neuroinflammation Mechanism. Brain Sciences. 2024;14(1).
7. Network MCN. Mayo Clinic Minute: Is Alzheimer’s Type 3 diabetes? 2017 [Available from: Retrieved from https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-is-alzheimers-type-3-diabetes/.
8. Australia D. What is type 3 diabetes? 2019 [Available from: Retrieved from https://www.diabetesaustralia.com.au/blog/what-is-type-3-diabetes/.
9. Rad S, Arya A, Karimian H, Madhavan P, Rizwan F, Koshy S, et al. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease. Drug Design, Development and Therapy 2018;12:3999—4021.
10. Li J, Liu F, Li Y. Advanced Glycation End Products-Induced Alzheimer’s Disease and Its Novel Therapeutic Approaches: A Comprehensive Review. Cureus. 2024;16(5).
11. Sim S, Kim S. Alzheimer’s disease and type 2 diabetes via chronic inflammatory response. Journal of Diabetes Research. 2014;2014:1–10.
12. Srinivasan K, Ramarao P, Ghosh B. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat serves as an alternative animal model for type 2 diabetes. Journal of Pharmacological and Toxicological Methods. 2005;52(1): 105-11.
13. Islam M, Loots D. Experimental animal models of type 2 diabetes: An update. . Methods and Findings in Experimental and Clinical Pharmacology. 2009;31(4):249-57.
14. Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin. Biomedicine & Pharmacotherapy. 2017;95:605-13.
15. Shunan D, Yu M, Guan H, Zhou Y. Neuroprotective effect of Betalain against AlCl3-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-κB) signaling pathway. Biomedicine & Pharmacotherapy. 2021;137:111369.
16. d’Isa R, Comi G, Leocani L, . Apparatus design and behavioural testing protocol for the evaluation of spatial working memory in mice through the spontaneous alternation T-maze. Sci Rep. 2021;11:21177.
17. Bancroft J, Gamble M. Theory and practice of histological techniques 6ed: Churchill Livingstone Elsevier.; 2008.
18. Maaliah M, addadin M, Abdalla S. Hypolipidemic and Hypoglycemic Effects of Silybum marianum (L.) Gaertn. (Milk Thistle) Ethanol Seed Extract in Streptozotocin-induced Diabetes in Rats. 2024;20(3):841-52.
19. Qinna N, Badwan A. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Devel Ther. 2015(25):15-25
20. Rehman Hu, Ullah K, Rasool A, Manzoor R, Yuan Y, Tareen AM, et al. Comparative impact of streptozotocin on altering normal glucose homeostasis in diabetic rats compared to normoglycemic rats. Scientific Reports. 2023;13(1):7921.
21. Obermaier-Kusser B, Mühlbacher C, Mushack J, Rattenhuber E, Fehlmann M, Haring HU. Regulation of glucose carrier activity by AlCl3 and phospholipase C in fat-cells. Biochemical Journal. 1988;256(2):515-20.
22. Chary R, Eerike M, Konda V, Arunachalam R, Yeddula V, Meti V, et al. Effect of aluminum chloride on blood glucose level and lipid profile in normal, diabetic and treated diabetic rats. Indian J Pharmacol 2017;49(5).
23. Ma X, Song M, Ren YYG, Hou J, Qin G, Wang W, et al. Albiflorin alleviates cognitive dysfunction in STZ-induced rats. 2021;13:8287-18297
24. .
25. Li D, Huang Y, Cheng B, Su J, Zhou WX, Zhang YX. Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze. J Alzheimers Dis. 2016;54(1):89-98.
26. Jadhav R, Kulkarni Y. Effects of baicalein with memantine on aluminium chloride-induced neurotoxicity in Wistar rats. Front Pharmacol. 2023;22(14).
27. Kaur K, Narang R, Singh S. AlCl3 induced learning and memory deficit in zebrafish. Neurotoxicology. 2022;92:67-76.
28. Hayat M, Khola N, Ahmed T. A Systematic Review of Preclinical Studies Investigating the Effects of Pharmacological Agents on Learning and Memory in Prolonged Aluminum-Exposure-Induced Neurotoxicity. Brain Sci 2025;15(6).
29. Mahdi O CS, Hidayat Baharuldin MT, Mohd Nor NH, Mat Taib CN, Jagadeesan S, Devi S, Mohd Moklas MA. . WIN55,212-2 Attenuates Cognitive Impairments in AlCl3 + d-Galactose-Induced Alzheimer's Disease Rats by Enhancing Neurogenesis and Reversing Oxidative Stress. Biomedicines. 2021;9(9).
30. Shata A, Elkashef W, Hamouda M, Eissa H. Effect of Artesunate vs Memantine in Aluminum Chloride Induced Model of Neurotoxicity in Rats
31. . Advances in Alzheimer's Disease. 2020;9(1):1-19
32. Akinola OB BS, Adediran RA, Adeniye KA, Abdulquadir FC. Characterization of prefrontal cortex microstructure and antioxidant status in a rat model of neurodegeneration induced by aluminium chloride and multiple low-dose streptozotocin. Metab Brain Dis 2015;30(6):1531-6.
33. Jajin E, Esmaeili A, Rahgozar1 S, Noorbakhshnia M. Quercetin-Conjugated Superparamagnetic Iron Oxide Nanoparticles Protect AlCl3-Induced Neurotoxicity in a Rat Model of Alzheimer’s Disease via Antioxidant Genes, APP Gene, and miRNA-101
34. Stanojevic JB ZM, Dragic M, Stojanovic IR, Ilic TV, Stevanovic ID, Ninkovic MB. Intermittent theta burst stimulation attenuates oxidative stress and reactive astrogliosis in the streptozotocin-induced model of Alzheimer's disease-like pathology. Front Aging Neurosci 2023;15.
35. Shaheen MA, Elshal LM, Mohamed GM, Reda S. Possible Effects of Empagliflozin on Hippocampal Structural Changes Associated with Alzheimer's Disease Induced by Aluminum Chloride in Adult Male Albino Rats ( Histological and Immunohistochemical Study). Zagazig University Medical Journal. 2025;31(1):228-55.
36. Adelodun ST, Ishola OA, Abijo AZ, Olatunji SY, Owolabi JO, Olanrewaju JA, et al. Aluminium chloride-induced hippocampal damage: CA3 hippocampal subfield involvement and the neuroprotective role of Buchholzia coriacea ethanolic seed extract. Phytomedicine Plus. 2021;1(4):100104.
37. Kanan DD, Aydemir I, Alizade A, Ebrahimi S, Aksu F. Investigation of Behavioral Changes and Histopathological Changes in the Brain in Alzheimer’s Modeled Mice with Aluminium Chloride (AlCl3). Cyprus J Med Sci. 2025;10:34-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Huda M Gargoum, Muftah M Muftah, Amira M Abelhamid, Kadija R Sharee (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
